TuHURA Biosciences (HURA) Amortizatization of Intangibles (2016 - 2024)
TuHURA Biosciences (HURA) posted quarterly Amortizatization of Intangibles of $1.1 million for Q3 2024, up 152.64% quarter-over-quarter from $438172.0 in Q2 2024.
TuHURA Biosciences (HURA) Amortizatization of Intangibles (2016 - 2024) Analysis & Trends
TuHURA Biosciences' Amortizatization of Intangibles history runs 3 years deep, the most recent figure standing at $1.1 million for Q3 2024.
- In Q3 2024, Amortizatization of Intangibles changed N/A year-over-year to $1.1 million; the TTM figure through Sep 2024 stood at $1.6 million (changed N/A YoY), while the FY2025 annual figure was $481424.0, down 62.34% from the prior year.
- Amortizatization of Intangibles for Q3 2024 stood at $1.1 million, up from $438172.0 in the prior quarter.
- The five-year high for Amortizatization of Intangibles was $1.1 million in Q3 2024, with the low at $17383.0 in Q1 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Amortizatization of Intangibles (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | - |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | - |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | - |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | - |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | - |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | 678,000.00 |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | - |
| 10 | TuHURA Biosciences | 37.61 Mn | 37.61 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2024 | 1.11 Mn |
| Sep 30, 2024 | 1.11 Mn |
| Jun 30, 2024 | 438,172.00 |
| Jun 30, 2024 | 438,172.00 |
| Mar 31, 2024 | 17,383.00 |
| Mar 31, 2024 | 17,383.00 |
| Mar 31, 2017 | 3,858.00 |
| Mar 31, 2017 | 3,858.00 |
| Dec 31, 2016 | 3,858.00 |
| Dec 31, 2016 | 3,858.00 |
| Sep 30, 2016 | 3,858.00 |
| Sep 30, 2016 | 3,858.00 |
| Jun 30, 2016 | 3,858.00 |
| Jun 30, 2016 | 3,858.00 |
| Mar 31, 2016 | 3,858.00 |
| Mar 31, 2016 | 3,858.00 |